ClpP is overexpressed in breast cancer,42 providing the potential for utilizing highly selective and potent ClpP activators as a novel approach to disrupt mitochondrial metabolic processes required for TNBC proliferation. This evidence concerns the gene CLPP and breast carcinoma.